Last €27.03 EUR
Change Today +0.08 / 0.30%
Volume 27.5K
KORI On Other Exchanges
EN Paris
As of 11:35 AM 08/20/14 All times are local (Market data is delayed by at least 15 minutes).

korian-medica (KORI) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/2/14 - €29.00
52 Week Low
08/21/13 - €17.89
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for KORIAN-MEDICA (KORI)

Related News

No related news articles were found.

korian-medica (KORI) Related Businessweek News

No Related Businessweek News Found

korian-medica (KORI) Details

Korian-Medica provides temporary and permanent dependency care services in France, Germany, Belgium, and Italy. As of April 30, 2014, it managed 506 nursing homes; and 87 specialised post-acute care clinics, which has approximately 2,400 beds in intermediate residences, as well as provides homecare and residences services. The company also operates retirement homes, médicalisées, and rehabilitation and psychiatric clinics. Korian-Medica was founded in 2001 and is based in Paris, France.

26,336 Employees
Last Reported Date: 04/30/14
Founded in 2001

korian-medica (KORI) Top Compensated Officers

Chief Executive Officer and Managing Director
Total Annual Compensation: €654.0K
Managing Director of Operations and Member of...
Total Annual Compensation: €76.4K
Deputy Chief Executive Officer
Total Annual Compensation: €58.5K
Total Annual Compensation: €129.0K
Compensation as of Fiscal Year 2013.

korian-medica (KORI) Key Developments

Korian-Medica Announces Consolidated Revenue Results and Unaudited Pro Forma Revenue Results for the Second Quarter and First Half of 2014

Korian-Medica announced consolidated revenues and unaudited pro forma revenues for the second quarter and first half of 2014. For the quarter, the group's consolidated revenues were EUR 605.7 million against EUR 354.9 million for the same period last year. The group's unaudited pro forma revenues were EUR 619.3 million against EUR 600.0 million for the same period last year. For the first half, the group's consolidated revenues were EUR 952.8 million, representing a significant increase of 45.4% against EUR 655.3 million for the same period last year. The group's unaudited pro forma revenues were EUR 1,230.4 million against EUR 1,186.8 million for the same period last year.

Korian - Medica's Shareholders Approves Distribution, Payable on July 31, 2014

The Combined General Meeting of Korian - Medica's Shareholders was held on 26 June 2014. The shareholders approved the distribution of a global amount of EUR 0.60 per share, with an option for each shareholder to receive the payment of its EUR 0.30 dividend in newly issued shares. This option is open from 3 to 22 July 2014 included. For the shareholders who will decide to exercise this option, the price of the newly issued shares shall be EUR 26.42 per share. The payment in cash and the delivery of the new shares will take place on 31 July 2014.

Korian-Medica Proposes Dividend, Payable on July 31, 2014; Announces Unaudited Consolidated Revenue Results for the First Quarter of 2014

Korian-Medica announced at the annual shareholders' meeting set to take place on June 26, 2014, a proposal will be put forward to pay a dividend of EUR 0.60 per share, with an option for payment in shares at EUR 0.30. Payment will be made on July 31, 2014. The company announced unaudited consolidated revenue results for the first quarter of 2014. For the period, the company reported consolidated revenue of EUR 350.9 million compared to EUR 304.2 million a year ago. The group pro-forma revenue was EUR 601.5 million compared to EUR 576.8 million a year ago.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KORI:FP €27.03 EUR +0.08

KORI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Generale de Sante SA €16.02 EUR -0.22
Le Noble Age €17.34 EUR -0.07
Orpea €48.62 EUR +0.165
View Industry Companies

Industry Analysis


Industry Average

Valuation KORI Industry Range
Price/Earnings 31.5x
Price/Sales 0.7x
Price/Book 1.2x
Price/Cash Flow 22.6x
TEV/Sales 0.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KORIAN-MEDICA, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at